cPTM-display: An encoded platform for the identification of chemically diverse cyclic peptides
Lead Research Organisation:
Imperial College London
Department Name: Chemistry
Abstract
Chemical probes provide a powerful route to modulate protein function in a time- and context-dependent manner, providing new insights into basic biology and tools to validate new drug targets. To maximise their impact on biology, there isa global ambition to develop tools against all cellular proteins by 2035. With probes to as little as 4% of the proteome currently, to achieve this goal there is an urgent need for new widely applicable strategies to identify new probes. In this proposal I will develop cPTM display, a cyclic peptide discovery platform, and apply it to probe discovery for a range of therapeutically relevant proteins. cPTM display will combine the massive library sizes that can be achieved using state-of-the-art peptide discovery platforms like mRNA display, with the much greater chemical diversity that can be accessed using synthetic chemistry. I will explore the range of different templated chemical transformations that can be encoded in cPTM display and the full scope of chemical post-translational modifications (cPTMs) that can be transferred to peptides. Resultant libraries of chemically diverse cyclic peptides will be applied to developing new chemical probes against therapeutically relevant proteins involved in the regulation of biological PTMs. In addition to chemical probe development, libraries will also be used to explore cellular PTM targeting. cPTM display will then be further expanded to the discovery of peptides that react covalently with their target. By combining aspects of organic synthesis and molecular biology, cPTM display will deliver a step change in our ability to develop chemically diverse cyclic peptides, enabling chemical probe development even for the most challenging protein targets.
Organisations
People |
ORCID iD |
| Louise Walport (Principal Investigator) |
Publications
Mathiesen I
(2024)
Discovering covalent cyclic peptide inhibitors of peptidyl arginine deiminase 4 (PADI4) using mRNA-display with a genetically encoded electrophilic warhead
in Communications Chemistry
Megušar P
(2024)
HPLC for at-line reaction monitoring and purification improves yield and purity of tRNA.
in Frontiers in molecular biosciences
| Description | We have developed a new approach to identify cyclic peptides that react irreversibly with a target protein of interest, recently published in 10.1038/s42004-024-01388-9. We have used this to develop some of the most potent and select covalent chemical probes against an enzyme, PADI4, that is involved in a range of diseases including Rheumatoid Arthritis and several cancers. |
| Exploitation Route | Our covalent peptide discovery approach can be used to create chemical probes or new drugs for related enzymes, several of which are involved in cardiovascular disease or thought to be good antibacterial targets. Our intent is that the method will also be extended further both by us and other academics to incorporate other covalent groups that would allow the screening approach to be applied to drug discovery for a much broader range of targets. |
| Sectors | Healthcare Pharmaceuticals and Medical Biotechnology |
| Description | Hosting Annual Work Experience |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Most summers we host 2 local A level students in the lab for a week. We use this time to expose them to our research and to increase their understanding of the possibilities of a science degree and what a career in science research might look like. Most of these students will be the first in the families to go to university and have no connections to adults working in research so they report after their visits that this has been very eye opening. |
| Year(s) Of Engagement Activity | 2019,2021,2023,2024,2025 |